The size of the MEA High-Resolution Melting Analysis Market was valued at USD 39.72 million in 2022. It is further projected to be growing at a CAGR of 2.07% and worth USD 44.00 billion by 2027.
Non-Invasive Prenatal Testing is used to identify mutations, genetic abnormalities, and polymorphisms. High-Resolution Melting Analysis is a branch of molecular biology which includes other techniques like genotyping.
During the procedure of High-Resolution Melting, the amplified region, termed an amplicon, is precisely heated at about 50 ËšC to 95 ËšC. Amid this temperature, the amplicon touches its melting point, and the two strands of DNA are parted or melt apart from each other. The splitting of these strands is noted and compared with that of a normal person. Abnormalities are identified in these DNA strands by this comparison, which yields mutations and other differences.
The growth of the Middle East and Africa High-Resolution Melting Analysis Market is mainly driven by the rising frequency of infectious diseases and genetic ailments, improving healthcare infrastructure, rising public-private investments in the genomics sector, and the upsurge in the count of the elderly populace. The benefits offered by HRM over genotyping are also among the chief drivers of the market. Low awareness, technological discrepancies, and the low penetration of High-Resolution Melting Analysis technology are among the market growth constraints.
This research report on MEA High-Resolution Melting Analysis Market has been segmented and sub-segmented into the following categories.
By Product and Service:
By Application:
By End User:
By Country:
Companies in the Middle East & Africa High-Resolution Melting Analysis market are Thermo Fisher Scientific Inc. (U.S.), F. Hofmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories (U.S.), and QIAGEN N.V. (Netherlands). Other players in the market include Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Illumina, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Novacyt (France), Azura Genomics (U.S.), Canon Biomedical (U.S.), and PREMIER Biosoft (U.S.), among others.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product and Service
5.1.1 Introduction
5.1.2 Reagents and Consumables
5.1.2.1 Specialized Pcr Reagents
5.1.2.2 Intercalating Dyes
5.1.3 Instruments
5.1.4 Software and Services
5.1.5 Y-o-Y Growth Analysis, By Product and Service
5.1.6 Market Attractiveness Analysis, By Product and Service
5.1.7 Market Share Analysis, By Product and Service
5.2 Application
5.2.1 Introduction
5.2.2 SNP Genotyping
5.2.3 Mutation Discovery
5.2.4 Species Identification
5.2.5 Pathogen Identification
5.2.6 Epigenetics
5.2.7 Other Applications
5.2.8 Y-o-Y Growth Analysis, By Application
5.2.9 Market Attractiveness Analysis, By Application
5.2.10 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Research Laboratories and Academic Institutes
5.3.3 Pharmaceutical and Biotechnology Companies
5.3.4 Hospitals and Diagnostic Centres
5.3.5 Other End Users
5.3.6 Y-o-Y Growth Analysis, By End User
5.3.7 Market Attractiveness Analysis, By End User
5.3.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product and Service
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product and Service
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product and Service
6.1.5.3 By Application
6.1.5.4 By End User
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 F. Hofmann-La Roche Ltd.
8.3 Bio-Rad Laboratories
8.4 QIAGEN N.V.
8.5 Agilent Technologies Inc.
8.6 BioMérieux S.A.
8.7 Illumina, Inc.
8.8 Meridian Bioscience, Inc.
8.9 Azura Genomics
8.10 Canon Biomedical
8.11 PREMIER Biosoft
8.12 Novacyt
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.